pluripotent
705 Results
Búsqueda avanzada
Mostrar
-
-
Human Pluripotent Stem Cell Characterization | Life Science Research | Merck
Discover Human Pluripotent Stem Cell characterization products: antibodies, antibody conjugates, and kits -
Pluripotent Mouse ES Cells | Life Science Research | Merck
To satisfy your pluripotent mouse ES cells culture needs, we provide the largest and most comprehensive range of products such as : unique mLIF formulations: ESGRO, PMEF feeder cells, ESGRO Complete Plus, and RESGRO. -
Mouse ES Cell Characterization | Life Science Research | Merck
Browse our extensive selection of mouse ES cell characterization antibodies for pluripotency and differentiation along with alkaline phosphatase kits for pluripotency quantification. -
Human Pluripotent Stem Cell Media | Life Science Research | Merck
PluriSTEM Human ES/iPS Medium is a specially formulated stem cell media that maintains human pluripotent stem cells in feeder-free and serum-free conditions with less frequent feeding and cell culture time. -
Press Release: Merck Obtains Global Licensing Agreement for induced Pluripotent Stem(iPS) Cell Patent Technology with iPS Academia Japan, Inc. (AJ)
Merck and iPS Academia Japan, Inc. (Kyoto, Japan) today announced a global licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio. -
Stem Cell Exhaustion | Life Science Research | Merck
As we age, our stem cells eventually lose their ability to divide and we are unable to replace the stem cells that have migrated, differentiated, or died. As a result, we show outward symbols of aging. -
Press Release: Merck Launches PluriSTEM™ Human ES/iPS Medium for the Expansion of Human Embryonic and Induced Pluripotent Stem Cells
Merck, today announced the availability of its PluriSTEM™ Human ES/iPS Medium for the routine expansion of human embryonic and induced pluripotent stem cells in feeder- and serum-free conditions with less frequent feeding and cell culture time. -
Press Release: Merck and VeriStem™ Technologies to Develop Purification Methods for Large-scale Stem Cell Production
Merck and VeriStem™ Technologies Inc. today announced a collaboration to develop optimized technologies for the removal of undifferentiated stem cells from pluripotent stem cell cultures. -
Event: "New Flow New Thinking" Asia Forum | Merck
Come join us and our distinguished speakers in this valuable sharing session and expect opportunities to engage with international and local scientists from top institutions who have published and moved their research forward using the Amnis technology. Imaging Flow, empower your scientific discovery with us!